BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Unternehmensdaten

Name BRIACELL THERAPEUTICSCS CORP - WARRANT

Firma BriaCell Therapeutics Corp.

Symbol BCTXW

Website https://briacell.com

Heimatbörse

NASDAQ

ISIN CA10778Y1126

Wertpapierart Aktie

Sektor Healthcare

Branche Biotechnology

CEO William V. Williams FCPA,

Land Kanada

Währung USD

Mitarbeiter 0,0 T

Adresse Bellevue Centre, V7T 2X1 West Vancouver

Ticker Symbole

Name	Symbol
NASDAQ	BCTXW

Weitere Aktien

Investoren, die BRIACELL THERAPEUTICSCS CORP - WARRANT halten, haben auch folgende Aktien im Depot:

AUSTRALIA & NEW ZEALAND BANKING GROUP LD 3.675% NTS 25/03/2024 Anleihe

Chausseria Aktie

Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.

Impressum Datenschutz Blog Community Feedback Changelog